Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.

Autor: Christensen TD; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Denmark. troels.dreier.christensen.01@regionh.dk., Buhl ASK; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Denmark.; Oncology Venture, Hoersholm, Denmark., Christensen IJ; Department of Pathology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark., Buhl IK; Oncology Venture, Hoersholm, Denmark.; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Balslev E; Department of Pathology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark., Knoop AS; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Danø H; Department of Oncology, Nordsjaellands Hospital, Copenhagen University Hospital, Hilleroed, Denmark., Glavicic V; Department of Oncology, Zealand University Hospital, Naestved, Denmark., Luczak A; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Langkjer ST; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Linnet S; Department of Oncology, Regional Hospital West Jutland, Herning, Denmark., Jakobsen EH; Department of Oncology, Vejle Sygehus, Vejle, Denmark., Bogovic J; Department of Oncology, Hospital of Southern Jutland, Soenderborg, Denmark., Ejlertsen B; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; The Danish Breast Cancer Cooperative Group, DBCG Secretariat, Rigshospitalet, Copenhagen, Denmark., Rasmussen A; Oncology Venture, Hoersholm, Denmark., Hansen A; Oncology Venture, Hoersholm, Denmark., Knudsen S; Oncology Venture, Hoersholm, Denmark., Jensen PB; Oncology Venture, Hoersholm, Denmark., Nielsen D; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730, Herlev, Denmark.

Publikováno v: Breast cancer (Tokyo, Japan) [Breast Cancer] 2020 Mar; Vol. 27 (2), pp. 266-276. Date of Electronic Publication: 2019 Oct 25.

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.

Autor: Buhl IK; Medical Prognosis Institute A/S, Hoersholm, Denmark.; Section for Molecular Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Santoni-Rugiu E; Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Denmark., Ravn J; Department of Thoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Hansen A; Medical Prognosis Institute A/S, Hoersholm, Denmark.; Oncology Venture Aps, Hoersholm, Denmark., Christensen IJ; Department of Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark., Jensen T; Medical Prognosis Institute A/S, Hoersholm, Denmark.; Oncology Venture Aps, Hoersholm, Denmark., Pratt B; Oncology Venture Aps, Hoersholm, Denmark., Askaa J; Medical Prognosis Institute A/S, Hoersholm, Denmark., Jensen PB; Medical Prognosis Institute A/S, Hoersholm, Denmark.; Oncology Venture Aps, Hoersholm, Denmark., Knudsen S; Medical Prognosis Institute A/S, Hoersholm, Denmark.; Oncology Venture Aps, Hoersholm, Denmark., Sørensen JB; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Publikováno v: PloS one [PLoS One] 2018 Mar 22; Vol. 13 (3), pp. e0194609. Date of Electronic Publication: 2018 Mar 22 (Print Publication: 2018).